p63 expression in epithelial ovarian tumors
β Scribed by O.B. POLI NETO; F.J. CANDIDO DOS REIS; L.N. ZAMBELLI RAMALHO; A.A. NOGUEIRA; J.M. De ANDRADE
- Book ID
- 109085551
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 169 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Vascular endothelial growth factor (VEGF) is a heparinβbinding, dimeric polypeptide with potent mitogenic effects on endothelial cells. VEGF expression has also been reported in ovarian epithelial tumors (OETs), which may be associated with gonadotropin stimulatioin. We recently reporte
Abnormal FHIT gene expression has been reported in a variety of epithelial tumors shown to harbor deletions of chromosome 3p14, the chromosomal assignment of this gene. Recently, we described loss of heterozygosity of 3p in a subset of epithelial ovarian cancers. To investigate a potential role of t
We have examined the roles of 2 putative tumor-suppressor genes, the p16 and p15 inhibitor-of-cyclin-dependentkinase genes, in the most commonly occurring epithelial tumors of the human ovary. Expression of p16 mRNA, examined by RT-PCR, was significantly reduced in 15 of the 48 tumors. Aberrant expr